OUR STRATEGY
Mission
Aneuryst develops de-risked small molecules that show promising efficacy.
Focus
We are disease-agnostic, targeting unmet needs for life-threatening conditions.
Pipeline
Our first lead candidates are for stroke and traumatic brain injury respectively.
CONTACT US
United States
Aneuryst, Inc.
211 East 43rd Street
Suite 710
New York City, New York
10017-8601
Ireland
Aneuryst (Ireland) Ltd.
Inniscarra, Main Street
Rathcoole
Co. Dublin
D24 E029